Newlystar-Medtech is a well established and professional supplier of Finished Pharmaceutical, Active
Pharmaceutical Ingredient(API) and Medical Devices. With a proven track record of passed years,
Newlystar-Medtech has been recognized by her customers as a high-quality and reliable supplier not
only on products, but also on assistance for audit and improvement of GMP level, quality management
system, EHS management system and registration dossier support, etc.
The essence of Newlystar-Medtech's activites, is a commitment to her customers with professional
service and high-quality products with effective cost and innovative solutions.
All pharmacists work in Newlystar-Medtech like a bridge link the customers and Chinese manufacturers,
especially, their professional working is to make the formulation manufacturers who is familiar with
Chinese Pharmacopoeia to understand well the international requirement,to ensure the success of
The advantages on professional working and strongly representative base on first-class manufacturing
partners in China, enable Newlystar-Medtech to provide her customers with a wide range and high-tech
products, best services and capabilities for their actions in tender, distributing and improvement in their
national healthcare system. Newlystar-Medtech also dedicates herself to sourcing quality medical
products for Chinese market.
Services and capabilities include:
1. Sourcing quality manufacturer
2. Contract manufacturing;
3. Conduct audits to suppliers (pharmaceutical plants);
4. Consultation on audit and improvement of GMP level, quality management system and EHS management system;
5. Regulatory support, registration dossier working;
Newlystar Medtech, your professional one-stop China Souring Partner.
Newlystar was founded on Sep, 2007. From the day of founding, we are dedicated to building a good platform for pharma trading which combined China facilities and global pharmaceutical distributors.Newlystar is very professional in quality management, GMP auditing, regulative affairs and business development, and we are willing to help our cooperative facilities to solve above mentioned barrier in formulation trading and develop international market together.
With the combined efforts, Newlystar has more than 10 cooperative facilities passed various GMP auditing from abroad, include INVIMA (Colombia), Peru, Anvisa (Brazil), TGA (Austrilia), Germany etc. And their products enter local market through Newlystar’s clients.
Now, our exportation markets already cover East European countries, Latin American countries, Central and southeast Asian countries, middle east and African. With the update of GMP system, we will have more and more facilities passing GMP auditing from US FDA, EMA, Contract manufacturing for European Pharmaceutical companies will take much larger partition in Newlystar’s total business.
From the year 2011, our turnover already exceeded 20 million USD on formulations. And the number keeps rising quickly these years.
Newlystar has an excellent team dedicated in pharma global business. The team is comprised of
experts in various areas, including experts onquality management, GMP, regulative affairs, business
development and management. More than 80% staffs are of bachelor degree and above, most are
majored in pharmacy, biology and medicine.
The combined efforts of every staff ensure the good quality of our products and long-term cooperation
with our global clients.